BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6729778)

  • 1. Some aspects of platelet glucose metabolism in thrombocytosis due to myeloproliferative disorders.
    Leoncini G; Maresca M; Balestrero F; Armani U; Piana A
    Thromb Res; 1984 May; 34(3):233-9. PubMed ID: 6729778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
    Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
    Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
    Hochhaus A; Mindner K; Ostermann G; Höche D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate overproduction in platelets of subjects affected with myeloproliferative disorders.
    Leoncini G; Maresca M; Armani U; Piana A
    Scand J Haematol; 1985 Aug; 35(2):229-32. PubMed ID: 4048869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
    Ryningen A; Apelseth T; Hausken T; Bruserud Ø
    Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
    Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
    Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytosis and Thrombosis: Is There Really a Correlation?
    Galvez C; Stein BL
    Curr Hematol Malig Rep; 2020 Aug; 15(4):261-267. PubMed ID: 32399765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytosis.
    Selroos O
    Acta Med Scand; 1973 May; 193(5):431-6. PubMed ID: 4717324
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
    Boughton BJ; Allington MJ; King A
    Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
    Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
    Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet glyoxalases in thrombocytosis.
    Leoncini G; Maresca M; Balestrero F; Armani U; Piana A
    Scand J Haematol; 1984 Jul; 33(1):91-4. PubMed ID: 6463589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
    Breuer JH; Harsányi V; Solti V; Hollán SR
    Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.
    Nishimura J; Okamoto S; Ibayashi H
    Thromb Haemost; 1979 Jun; 41(4):787-95. PubMed ID: 483250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory assessment of a patient with thrombocytosis.
    Appleby N; Angelov D
    Br J Hosp Med (Lond); 2017 Oct; 78(10):558-564. PubMed ID: 29019736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in vitro platelet activation on platelet derived nitric oxide production in healthy humans and in chronic myeloproliferative diseases with elevated platelet counts.
    Rejto L; Huszka M; Káplár M; Udvardy M
    Platelets; 2003 Aug; 14(5):283-6. PubMed ID: 14524361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary thrombocythaemia in childhood.
    Linch DC; Hutton R; Cowan D; Moore AR; Richards JD; Wilkinson LS
    Scand J Haematol; 1982 Jan; 28(1):72-6. PubMed ID: 7071518
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract]   [Full Text] [Related]  

  • 20. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
    Zucker S; Mielke CH
    J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.